Navigation Links


Signs in Medical Technology

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... more than three million people in Europe. signs and symptoms of RA include pain, stiffness and ... infection. Patients should be monitored for signs and symptoms of infection before, during and ... receiving SIMPONI should be monitored closely for signs and symptoms of active tuberculosis during and ...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... emotion, lack of interest and depressive signs and symptoms(1). Manic symptoms of bipolar I ... Syndrome (NMS) has been reported with Zyprexa. If signs and symptoms appear, immediate discontinuation is ... diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatinine phosphokinase, ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... weeks experienced significant improvements in signs and symptoms through week 24, compared with ... and showed SIMPONI to be effective in improving signs and symptoms of RA. Eighty percent of patients ... may benefit these patients by reducing the signs and symptoms of rheumatoid arthritis." ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... weeks provided persistent improvements in the signs and symptoms in patients with psoriatic arthritis ... 20. At least 50 percent improvement in arthritis signs and symptoms (ACR 50) was seen in 47 of 70 ... 100 mg experienced sustained improvements in the signs and symptoms of psoriatic arthritis through two ...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

... improvement in physical function and disease signs and symptoms over two years. Patients received ... methotrexate experienced a reduction in disease signs and symptoms at one year compared with patients ... a 50 or 70 percent improvement in their disease signs and symptoms at 132 weeks, 66.7 percent (ACR50) ...

ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease

... ability to effectively and conveniently treat signs and symptoms of dry eye disease and provide fast ... study enrolled 38 patients who exhibited signs and symptoms consistent with moderate dry eye ... bromfenac compared to baseline on the objective signs of conjunctival staining (Lissamine Green test) ...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

... for the remote monitoring of patients' vital signs by healthcare professionals. The new LifeShirt ... continuously collecting and fusing multiple vital signs into a validated, actionable health ... software to fuse data from multiple vital signs into a single index of health status that will ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... active Crohn's disease for the reduction of the signs and symptoms in patients who have an inadequate ... indications: Reducing signs and symptoms, inhibiting the progression of ... combination with methotrexate. Reducing signs and symptoms in patients with active AS. ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... Cimzia(R) is also approved for reducing signs and symptoms of Crohn's disease and maintaining ... (FDA) has approved Cimzia (R) for reducing signs and symptoms of Crohn's disease and maintaining ... be closely monitored for the development of signs and symptoms of infection during and after ...

RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

... selective alpha blocker for the treatment of the signs and symptoms of BPH, produces rapid improvements ... fast acting, effective and safe treatment for the signs and symptoms associated with BPH." BPH is ... 923 generally healthy men ages 50 or older with signs and symptoms of BPH, including a peak urine flow ...

ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;

... quality of life as well as in measures of dry eye signs and symptoms. A patient registry study is ... registry study, "Effect of Lacrisert(R) on the signs and Symptoms of Dry Eye in Contact Lens Wearers" ... and 53% experienced an improvement in dry eye signs while wearing contact lenses. It was also ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

... indicated in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease ... reported falling asleep without perceived warning signs during activities of daily living, including ... and Drug Administration for the treatment of the signs and symptoms of idiopathic Parkinson's disease ...

Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye

... statistically significant improvement with signs and symptoms in patients suffering from ... effect on multiple efficacy variables for both signs and symptoms at Month 1 and Month 3. . These ... new trial demonstrating efficacy on both dry eye signs and symptoms" said Jerome Martinez, CEO of ...

Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium

... in improving the clinical signs and symptoms of rosacea. According to the ... rosacea sufferers hope and a way to control the signs and symptoms of this potentially life-disruptive ... as well as through patient assessments of signs and symptoms of rosacea and skin tolerance. ...

AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi

... for stroke, learn to quickly identify the warning signs and be better prepared should they themselves or ... of a video in which Tedy describes the warning signs of stroke. The national stroke awareness ... with stroke and educating others about warning signs - will be posted monthly beginning January 29, ...

ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium

... that ecabet sodium has the ability to treat signs and symptoms of dry eye syndrome. Ecabet sodium ... environmental clinical trials for improvement in signs and two successful Phase III controlled chamber ... of a lower strength of Xibrom to treat the signs and symptoms of dry eye disease in the first half ...

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

... severe disorganized or catatonic behavior. These signs and symptoms are associated with marked social or ... of schizophrenia consist of characteristic signs and symptoms that have been present for a ... (NMS) has been reported with olanzapine. If signs and symptoms appear, immediate discontinuation ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure ... should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or ... Physicians and patients should remain alert for signs and symptoms of GI ulceration and hemorrhage and ...

Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds

... that grape intake lowered blood pressure and signs of heart muscle damage, and improved heart ... throughout their bodies, and fewer signs of heart muscle damage than the rats that ate the ... unit of time. The researchers also looked for signs of inflammation, oxidative damage and other ...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

... Patients were assessed for improvement in signs and symptoms of RA. The primary endpoint for the ... together with methotrexate in the treatment of signs and symptoms and in the prevention of joint ... Patients were assessed for improvement in signs and symptoms of RA. The primary endpoint of the ...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

... methotrexate experienced a reduction in disease signs and symptoms at one year compared with ... with ACTEMRA experienced an improvement in the signs and symptoms of RA and achieved remission ... improvement in physical function and disease signs and symptoms. Patients received either ACTEMRA ...

ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments

... (RA) achieved significant improvements in signs and symptoms when treated with ACTEMRA(R) ... achieved a 20 percent reduction (ACR20)(1) in RA signs and symptoms, compared with 10 percent ... new treatment option for managing the chronic signs and symptoms of this debilitating disease." The ...

Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting

... by early preclinical study results showing signs of efficacy in inflammatory bowel disease targets ... larazotide acetate was well tolerated and showed signs of efficacy in preventing immunologic changes ... effects observed on intestinal permeability, signs and symptoms. Clinical findings included: -- ...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

... on April 22, 2008 for reducing signs and symptoms of moderate to severe Crohn's ... CIMZIA was approved in April 2008 for reducing signs and symptoms of Crohn's disease and maintaining ... CIMZIA. Monitor patients receiving CIMZIA for signs and symptoms of active tuberculosis, including ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... active Crohn's disease for the reduction of the signs and symptoms in patients who have an inadequate ... for the following indications: -- Reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- Reducing signs and symptoms in patients with active AS. -- ...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

... Colombel. CIMZIA is approved for reducing the signs and symptoms of Crohn's disease and maintaining ... CIMZIA was approved in April 2008 for reducing signs and symptoms of Crohn's disease and maintaining ... CIMZIA. Monitor patients receiving CIMZIA for signs and symptoms of active tuberculosis, including ...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

... significantly improves a broad range of clinical signs of vulvovaginal atrophy, including petechiae, ... of treatment, the mean scores for common clinical signs of vaginal atrophy were decreased by ... evident at week 4, as the mean scores of all signs were significantly decreased by Ophena(TM) when ...

Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS

... of Betaseron by patients with the earliest signs of MS. Two-thirds of patients (67 percent) in the ... Betaseron treatment in patients with the earliest signs of the disease delayed the progression to CDMS ... population of patients with the earliest signs of MS, including patients with mono- or ...

NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect

... developing as a drug for the treatment of the signs and symptoms of osteoarthritis. NicOx' phase 3 ... efficacy of new drugs for the treatment of the signs and symptoms of osteoarthritis. The main ... phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase ...

Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months

... No clinically significant decreases in vital signs were observed and all patients recovered ... of schizophrenia consist of characteristic signs and symptoms that have been present for a ... of time during a one-month period, with some signs of the disorder persisting for at least six ...

First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting

... action for Hispanic families to watch for early signs of AD among their loved ones and speak with a ... often, Hispanics dismiss the symptoms of AD as signs of normal aging and wait years before consulting ... with Hispanic patients to start screening for signs of dementia at a younger age, potentially at 55 ...

Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference

... Syndrome (PDSS), which describes a range of signs and symptoms such as sedation, delirium, ... of schizophrenia consist of characteristic signs and symptoms that have been present for a ... of time during a one-month period, with some signs of the disorder persisting for at least six ...

Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

... (MTX) experienced significant improvements in the signs and symptoms of rheumatoid arthritis (RA) as well ... MTX achieved at least 20 percent improvement in signs and symptoms of RA (ACR 20), compared to 33 ... combination with MTX experienced improvement in signs and symptoms of arthritis as well as in disease ...

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... as well as total neuropathy score (TNS) to assess signs and symptoms of the condition. A quantitative ... and TNS to quantify neurologic exam and assess signs and symptoms of the condition. For each subject ... expression of stem cell-specific markers. The signs and symptoms of diabetic peripheral neuropathy ...

NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study

... to assess naproxcinod's efficacy in relieving the signs and symptoms of osteoarthritis of the hip and ... as an investigational drug for treating the signs and symptoms of osteoarthritis. Naproxcinod is ... the efficacy of drugs for treating the signs and symptoms of osteoarthritis and the same as ...

Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission

... Abbott. HUMIRA is indicated for reducing signs and symptoms and inducing and maintaining ... therapy. HUMIRA is indicated for reducing signs and symptoms and inducing clinical remission in ... HUMIRA is also approved by the FDA for reducing signs and symptoms, inducing major clinical ...

Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease

... alpha) antibody approved for reducing signs and symptoms of Crohn's disease and maintaining ... Monitor patients receiving Cimzia(R) for signs and symptoms of active tuberculosis, including ... be closely monitored for clinical and laboratory signs of active HBV infection throughout therapy and ...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

... for the following indications: -- Reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- Reducing signs and symptoms in patients with active AS. -- Reducing signs and symptoms and inducing and maintaining ...

Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea

... clinical improvement. Patient assessments of signs and symptoms of rosacea and skin tolerance were ... that provide sustained relief of its principal signs and symptoms. Dr. Arisa Ortiz from the ... burning, stinging, and dryness, all of which are signs and symptoms associated with acne rosacea. ...

U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older

... offers another treatment option to help improve signs and symptoms of this serious disease in pediatric ... statement is: ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, ... About ORENCIA ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, ...
Other Contentsmassesmassesmassesmassesmassesmassesscrotalscratchscratchscratchscratchscurvyallergiesallergiesallergiesallergiesallergiesseasonalseasonalseasonalseasonalseasonalseborrhea
(Date:11/24/2009)..., Rocket science is opening new doors to understa...affect the hearing of a marine mammal or if they ...ial sized X-ray scanners that NASA uses to detect ...ockets is now allowing scientists to peek inside t...detailed three-dimensional replicas of a whale,s h...
(Date:11/24/2009)..., Stents that keep weakened and flabby arteries f...er six months, those stents are no longer needed -...unnecessary. Previously, doctors had no choice but...n of Tel Aviv University,s Department of Biomedica...iber platform that carries drugs where they,re nee...
(Date:11/24/2009)..., Springer and the American College of Medical To...orate on the publication of the Journal of Medica...CMT, beginning in March 2010. It was previously p... , The Journal of Medical Toxicology , an inter...dvancing the science and practice of medical toxic...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Social background weighs heavily on teenage diet 58327 1Social background weighs heavily on teenage diet 58327 2
(Date:11/29/2009)...urine production, experts say , , SUNDA...during the night to urinate shouldn,t automaticall...hing-related sleep disorder, could be the cause. ,... or nocturia, is comparable to loud snoring as a m...hich soft tissue in the throat blocks the flow of ...
(Date:11/28/2009)... Get ready for advanced visualization to become ...iemens introduces syngo. via(1) at the 95th...iological Society of North America (RSNA) from Nov...825, East Building/Lakeside Center, Hall D) in Chi...ng software for multimodality reading of clinical ...
(Date:11/27/2009)...e-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSIGQ...gy products and semiconductor systems, today annou...holders has been scheduled for Friday, April 30, 2... announced in due course. As previously announced...tephen Bershad, a holder of greater than ten perce...
(Date:11/27/2009)...irstCall/ -- The Gymboree Corporation (Nasdaq: GY...resent at the NASDAQ OMX 23rd Investor Program, wh...England, on Wednesday, December 2, 2009, at 11:45 ...he Gymboree Corporation,s presentation over the In...n "Our Company" at the bottom of the page, go to "...
(Date:11/27/2009)... announced that it has become a national sponsor o...profit organizations dedicated to arthritis resear... Delray Beach, FL (Vocus) November 27, 200...any specializing in the marketing and retail distr...nced today that is has become a national sponsor o...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
Other TagsappearsscarscarleavesflipannuallyreservereserveharvestharvestplannedOther Tagsbusy 2busy 3busy 4busy 5busy 6close 2close 3close 4close 5close 6close 7close 8close 9close 10past 2past 3past 4past 5past 6past 7past 8past 9past 10fare 2fare 3right 2right 3right 4right 5right 6right 7right 8right 9right 10habitat 2habitat 3habitat 4habitat 5habitat 6habitat 7underground 2engage 2engage 3engage 4figure 2figure 3figure 4figure 5figure 6figure 7figure 8